Abstract:BackgroundActivation of nuclear factor kappa B (NFκB) and subsequent inflammation occurs in various models of myocardial ischemia/reperfusion injury (I/RI). Thus, inhibition of NFκB‐mediated inflammation is of clinical significance for improving post‐ischemic recovery. miR‐181c‐5p was significantly up‐regulated in the early phase of myocardial infarction in patients. However, whether miR‐181c‐5p mediates cardiac I/RI through NFκB‐mediated inflammation is unknown. We aimed to explore the role and mechanism of miR‐181c‐5p in inflammation during I/RI in H9C2 cardiomyocytes under hypoxia/reoxygenation (H/R) injury.Methods and ResultsIn response to H/R (6 hours hypoxia followed by 6 hours reoxygenation), the expression of miR‐181c‐5p was significantly up‐regulated, suggestive of a potential role of miR‐181c‐5p in the pathology of myocardial I/RI. In addition, H/R significantly induced H9C2 cardiomyocytes injury, evidenced by increased release of lactic acid dehydrogenase (LDH, cell injury marker) and reduced cell viability, concomitantly with enhanced phosphorylation and degradation of IκBα, p65 nuclear translocation and increased production of NFκB‐mediated pro‐inflammatory cytokines tumor necrosis factor α (TNFα), interleukin (IL)6 and IL1β. To demonstrate the potential role of miR‐181c‐5p in H/R‐induced cell inflammation and injury, H9C2 cardiomyocytes were transfected with the miR‐181c‐5p agomir or its negative control. Overexpression of miR‐181c‐5p significantly aggravated H/R‐induced cell injury (increased LDH level and reduced cell viability) and exacerbated NFκB‐mediated inflammation [greater phosphorylation and degradation of IκBα, p65 nuclear translocation and increased levels of pro‐inflammatory cytokines (TNFα, IL6, IL1 β)]. By using computational prediction algorithms (TargetScan and miRDB), protein tyrosine phosphatase non‐receptor type 4 (PTPN4) was predicted as a potential target gene of miR‐181c‐5p, as also verified by the luciferase reporter assay. Indeed, overexpression of miR‐181c‐5p significantly attenuated the mRNA and protein expression of PTPN4 in H9C2 cardiomyocytes, while knockdown of PTPN4 significantly aggravated H/R‐induced enhancement of LDH level, phosphorylation and degradation of IκBα and pro‐inflammatory cytokines level, which mimicked the pro‐inflammatory effects of miR‐181c‐5p.ConclusionsmiR‐181c‐5p exacerbates H/R‐induced cardiomyocyte injury and NFκB‐mediated inflammation via targeting PTPN4, and the miR‐181c‐5p/PTPN4 signaling may be a novel target to combat myocardial I/RI.Support or Funding InformationThe work was supported by GRF (17117217M, Research Grants Council of Hong Kong).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Cardiac Fibroblast Activation Induced by Oxygen–Glucose Deprivation Depends on the HIF-1α/miR-212-5p/KLF4 Pathway

Retracted: MicroRNA‐132 Protects H9c2 Cells Against Oxygen and Glucose Deprivation‐evoked Injury by Targeting FOXO3A

MicroRNA-101a Inhibits Cardiac Fibrosis Induced by Hypoxia Via Targeting TGFβRI on Cardiac Fibroblasts

MicroRNA-101 Protects Cardiac Fibroblasts from Hypoxia-Induced Apoptosis Via Inhibition of the TGF-β Signaling Pathway

Absence of miR-223-3p ameliorates hypoxia-induced injury through repressing cardiomyocyte apoptosis and oxidative stress by targeting KLF15.

Abstract 298: Flavin Containing Monooxygenase 2 in Cardiac Fibrosis

The Protective Role of Bfgf in Myocardial Infarction and Hypoxia Cardiomyocytes by Reducing Oxidative Stress Via Nrf2

CircHIPK3 regulates cardiac fibroblast proliferation, migration and phenotypic switching through the miR-152-3p/TGF-β2 axis under hypoxia.

miRNA-146a-5p Inhibits Hypoxia-Induced Myocardial Fibrosis Through EndMT

MicroRNA‐181c‐5p Enhances NFκB‐mediated Inflammation Via Targeting PTPN4 in H9C2 Cardiomyocytes During Hypoxia/ Reoxygenation

Mir-145 Attenuates Cardiac Fibrosis Through the AKT/GSK-3/-catenin Signaling Pathway by Directly Targeting SOX9 in Fibroblasts

MicroRNA-495 Inhibits the High Glucose-Induced Inflammation, Differentiation and Extracellular Matrix Accumulation of Cardiac Fibroblasts Through Downregulation of NOD1.

HIF-1/AKT Signaling-Activated PFKFB2 Alleviates Cardiac Dysfunction and Cardiomyocyte Apoptosis in Response to Hypoxia

MicroRNA-186-5p Inhibits H9c2 Cells Apoptosis Induced by Oxygen-Glucose Deprivation by Targeting ERK1/2

circCELF1 Inhibits Myocardial Fibrosis by Regulating the Expression of DKK2 Through FTO/m6A and miR-636

Microrna-214 Mediates Isoproterenol-Induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts

Downregulation of Microrna-302B-3p Relieves Oxygen-Glucose Deprivation/re-Oxygenation Induced Injury in Murine Hippocampal Neurons Through Up-Regulating Nrf2 Signaling by Targeting Fibroblast Growth Factor 15/19

Hypoxic cardiomyocyte-derived exosomes regulate cardiac fibroblast activation, apoptosis, migration and ferroptosis through miR-208a/b

Fibroblast‐derived miR‐425‐5p alleviates cardiac remodelling in heart failure via inhibiting the TGF‐β1/Smad signalling

Hypoxia Inducible Factor-1 Mediates Expression Of Mir-322: Potential Role In Proliferation And Migration Of Pulmonary Arterial Smooth Muscle Cells

Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation